Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | CETP | P11597 | 3/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.36 |
| ▸ | MME | P08473 | 4/20 | 0.36 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9640977 | 1.00 | CYP2C19 (0.60) | CYP2C19CETPFFAR3MMETBXAS1 | |
| SCHEMBL30186714 | 1.00 | CYP2C19 (0.60) | CYP2C19CETPFFAR3MMETBXAS1 | |
| SCHEMBL1812100 | 0.97 | CYP2C19 (0.56) | CYP2C19CETPFFAR3MMETBXAS1 | |
| SCHEMBL1055977 | 0.92 | — | — | |
| SCHEMBL245571 | 0.87 | — | — | |
| SCHEMBL30716833 | 0.87 | CYP2C19 (0.42) | CYP2C19CETPFFAR3ALDH1A1 | |
| Hydrochloric Acid SCHEMBL11173735 | 0.84 | — | — | |
| SCHEMBL887735 | 0.81 | CYP2C19 (0.56) | CYP2C19CETPFFAR3MMETBXAS1 | |
| SCHEMBL6557573 | 0.81 | CYP2C19 (0.45) | CYP2C19CETPFFAR3MMETSHR | |
| Cyanide SCHEMBL11178722 | 0.80 | CYP2C19 (0.38) | CYP2C19FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024166832-A1 | FRAGRANCE COMPOSITION, AND METHOD FOR PRODUCING 1-ETHYLCYCLOHEXANECARBOXYLIC ACID ESTER | 三菱瓦斯化学株式会社 | 2024-08-15 | — | — | WO | claimed |
| EP-3510056-B2 | PROCESS OF PREPARING POLYOLEFIN WITH THE DISCONTINUOUS ADDITION OF A THERMAL RUNAWAY REDUCING AGENT | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-07-19 | — | — | EP | claimed |
| EP-2543684-B1 | Process for the manufacture of isotactic polypropylene | BOREALIS AG (AT) | 2016-12-21 | — | — | EP | claimed |
| CN-101811989-A | Production method of trans-4-isopropyl hexahydrobenzoic acid-4'-biphenylcarbonitrile | JIANGSU KANGXIANG GROUP COMPANY | 2010-08-25 | — | — | CN | claimed |
| US-6852193-B2 | Semi-solid one- or two-part compositions | LOCTITE (R&D) LIMITED (IE) | 2005-02-08 | — | — | US | claimed |
| US-20030171467-A1 | Semi-solid one- or two-part compositions | LOCTITE (R&D) LIMITED (IE) | 2003-09-11 | — | — | US | claimed |
| WO-2001092434-A1 | SEMI-SOLID ONE- OR TWO-PART COMPOSITIONS | LOCTITE (R & D) LIMITED (IE) | 2001-12-06 | — | — | WO | claimed |
| EP-0208486-A2 | Process for producing tissue plasminogen activator | Toyo Boseki Kabushiki Kaisha (JP) | 1987-01-14 | — | — | EP | claimed |
| US-12564879-B2 | Copper paste for joining, method for manufacturing joined body, and joined body | RESONAC CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-4692041-A1 | METHOD FOR PRODUCING BIO-DERIVED ESTER COMPOUND, BIO-DERIVED ESTER COMPOUND PRODUCED THEREBY, COSMETIC OR DETERGENT CONTAINING BIO-DERIVED ESTER COMPOUND, AND METHOD FOR REDUCING ODOR OF ESTER COMPOUND | ADEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260015443-A1 | POLYPROPLYENE COMPOSITIONS WITH ENHANCED STRAIN HARDENING AND METHODS OF PRODUCING THE SAME | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250387833-A1 | METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE | RESONAC CORP (JP) | 2025-12-25 | — | — | US | disclosed |
| US-12466805-B2 | Pharmaceutical compounds | ALMAC DISCOVERY LIMITED (GB) | 2025-11-11 | — | — | US | disclosed |
| US-20250293091-A1 | METHOD FOR PRODUCING SUBSTRATE HAVING THROUGH-SILICON VIAS, SUBSTRATE HAVING THROUGH-SILICON VIAS, AND COPPER PASTE FOR THROUGH-SILICON VIA FORMATION | RESONAC CORPORATION (JP) | 2025-09-18 | — | — | US | disclosed |
| US-4221894-A | MAGNESIUM HALIDE, TITANIUM, ORGANOALUMINUM, ESTER | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1980-09-09 | — | — | US | disclosed |
| US-4187196-A | REACTING HALOGENATED TITANIUM COMPOUND WITH MAGNESIUM OR MANGANESE DIHALIDE | MONTEDISON S.P.A. (IT) | 1980-02-05 | — | — | US | disclosed |
| US-4156063-A | USING A CATALYST CONTAINING THE REACTION PRODUCT OF AN ALUMINUM COMPOUND AND AN ESTER WITH A SUPPORT CONTAINING THE REACTION PRODUCT OF A TITANIUM COMPOUND AND A MAGNESIUM OR MANGANESE BIHALIDE | Montecanti Edison, S.p.A. (IT) | 1979-05-22 | — | — | US | disclosed |
| US-4143223-A | TITANIUM, HALOGEN, ALUMINUM, ESTER AND AN ALCOHOL | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1979-03-06 | — | — | US | disclosed |
| US-4115319-A | COMPOUNDS CONTAINING MAGNESIUM, TITANIUM, AND HALOGEN | MONTEDISON S.P.A. (IT) | 1978-09-19 | — | — | US | disclosed |
| US-4107414-A | Process for the stereoregular polymerization of alpha olefins | MONTECATINI EDISON S.P.A. (IT) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387833-A1 | METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE | C5, C9, CUTA | CYP2C19 979/4885CETP 1026/4885FFAR3 4830/4885 |
| US-12466805-B2 | Pharmaceutical compounds | USP19, USP18, UBE2I | CYP2C19 162/4885CETP 734/4885FFAR3 3840/4885 |
| US-20260015443-A1 | POLYPROPLYENE COMPOSITIONS WITH ENHANCED STRAIN HARDENING AND METHODS OF PRODUCING THE SAME | PFN1, PSD, FDFT1 | CYP2C19 3135/4885CETP 1867/4885FFAR3 881/4885 |
| US-12564879-B2 | Copper paste for joining, method for manufacturing joined body, and joined body | DCX, DNAJA2, DNAJA1 | CYP2C19 495/4885CETP 252/4885FFAR3 4587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.